A XM não fornece serviços a residentes nos Estados Unidos da América.

Asian currencies eke out gains on muted dollar



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>EMERGING MARKETS-Asian currencies eke out gains on muted dollar</title></head><body>

.

Thailand baht gains most among Asian FX

RBI holds interest rates at 6.50%

Shanghai stocks reverse Tuesday's gains

By Sneha Kumar and Archishma Iyer

Oct 9 (Reuters) -Most emerging Asian currencies registered minor gains against a broadly muted dollar on Wednesday, as investors sought data to assess the Federal Reserve's rate cut path.

Thailand's baht THB=TH appreciated as much as 0.8% before pulling back gains to 0.3%. It is the second-best performing currency in the region this year, after the Malaysian ringgit, with a near 2% jump.

The currency of Southeast Asia's second-largest economy has been buoyed recently by U.S. interest rate cut bets, stabilising politics and economic growth.

"For the baht, there could be some USD-selling interest from market players especially exporters as they have been waiting for the baht to weaken a bit," said Poon Panichpibool, a markets strategist at Krung Thai Bank.

At 0744 GMT, the dollar index inched higher to 102.64.

The Indonesian rupiah IDR= was up 0.2%, while the Malaysian ringgit MYR= rose marginally.

The Philippines peso PHP= was a notable outlier, falling about 0.3% to its lowest since mid-August.

"Until the sentiment-driven market aligns with the Fed’s underlying outlook for lower inflation and interest rates, currencies are likely to lack direction from markets over-reacting to better- or worse-than-expected data," analysts from DBS wrote.

Global investors are now awaiting a key inflation print from the U.S., as well as minutes from the Fed's latest monetary policy meeting later in the day, for a better sense of where interest rates could be headed.

Falling U.S. rates boost the attractiveness of riskier emerging market assets, particularly in Southeast Asia.

In India, stocks .NSEI rose as much as 0.9% after the Reserve Bank of India changed its policy stance to neutral and opened the door to cuts as early as December, while the rupee INR=IN remained flat.

The central bank maintained its key interest rate steady at 6.50% as expected.

Elsewhere, the Bank of Korea is expected to move with a 25-basis points cut later this week.

Among other Asian equities, Taipei .TWII rose as much as 1.2% to its highest level in nearly two weeks, before ending 0.2% higher.

Shares in Singapore .STI rose 0.5%, while Bangkok .SETI and Kuala Lumpur .KLSE inched up 0.2% each.

Meanwhile, equities in Shanghai .SSEC snapped a 10-day winning streak, tumbling 6.6% and erasing all gains from the previous session.

The index had risen as much as 10.1% on Tuesday on anticipation of more strong stimulus measures from Beijing which failed to materialise.

Markets in South Korea were closed for a public holiday.


HIGHLIGHTS:

** Thailand approves $400 mln investment by Continental AG to expand tyre facility

** India, S. Korea bonds to join FTSE Russell government indexes in 2025

** China's finance ministry to detail fiscal policy on Saturday


Asian currencies and stocks at 0744 GMT

COUNTRY

FX RIC

FX DAILY %

FX YTD %

INDEX

STOCKS DAILY %

STOCKS YTD %

Japan

JPY=

-0.20

-5.00

.N225

0.89

17.37

China

CNY=CFXS

+0.02

+0.49

.SSEC

-6.62

9.54

India

INR=IN

+0.01

-0.89

.NSEI

0.53

15.72

Indonesia

IDR=

+0.16

-1.41

.JKSE

-0.48

3.41

Malaysia

MYR=

0.05

+7.17

.KLSE

0.19

12.66

Philippines

PHP=

-0.30

-2.83

.PSI

-1.50

15.11

S.Korea

KRW=KFTC

-

-4.31

.KS11

-

-2.29

Singapore

SGD=

-0.03

+1.15

.STI

0.47

10.87

Taiwan

TWD=TP

0.00

-4.61

.TWII

0.21

26.37

Thailand

THB=TH

+0.25

+2.03

.SETI

0.17

2.79


Graphic: World FX rates https://tmsnrt.rs/2RBWI5E

Asian stock markets https://tmsnrt.rs/2zpUAr4


Reportingby Sneha Kumar and Archishma Iyer in Bengaluru; Editing by Kim Coghill and Varun H K

</body></html>

Isenção de Responsabilidade: As entidades do XM Group proporcionam serviço de apenas-execução e acesso à nossa plataforma online de negociação, permitindo a visualização e/ou uso do conteúdo disponível no website ou através deste, o que não se destina a alterar ou a expandir o supracitado. Tal acesso e uso estão sempre sujeitos a: (i) Termos e Condições; (ii) Avisos de Risco; e (iii) Termos de Responsabilidade. Este, é desta forma, fornecido como informação generalizada. Particularmente, por favor esteja ciente que os conteúdos da nossa plataforma online de negociação não constituem solicitação ou oferta para iniciar qualquer transação nos mercados financeiros. Negociar em qualquer mercado financeiro envolve um nível de risco significativo de perda do capital.

Todo o material publicado na nossa plataforma de negociação online tem apenas objetivos educacionais/informativos e não contém — e não deve ser considerado conter — conselhos e recomendações financeiras, de negociação ou fiscalidade de investimentos, registo de preços de negociação, oferta e solicitação de transação em qualquer instrumento financeiro ou promoção financeira não solicitada direcionadas a si.

Qual conteúdo obtido por uma terceira parte, assim como o conteúdo preparado pela XM, tais como, opiniões, pesquisa, análises, preços, outra informação ou links para websites de terceiras partes contidos neste website são prestados "no estado em que se encontram", como um comentário de mercado generalizado e não constitui conselho de investimento. Na medida em que qualquer conteúdo é construído como pesquisa de investimento, deve considerar e aceitar que este não tem como objetivo e nem foi preparado de acordo com os requisitos legais concebidos para promover a independência da pesquisa de investimento, desta forma, deve ser considerado material de marketing sob as leis e regulações relevantes. Por favor, certifique-se que leu e compreendeu a nossa Notificação sobre Pesquisa de Investimento não-independente e o Aviso de Risco, relativos à informação supracitada, os quais podem ser acedidos aqui.

Aviso de risco: O seu capital está em risco. Os produtos alavancados podem não ser adequados para todos. Recomendamos que consulte a nossa Divulgação de Riscos.